Literature DB >> 37876

Antihypertensive action of beta-adrenoceptor blockade and the renin-angiotensin system.

I Gavras, H Gavras, H R Brunner, C S Liang.   

Abstract

1 The regulation of renin secretion is mediated by way of adrenoceptors. The role of alpha-adrenoceptors remains controversial, whereas it is generally accepted that activation of beta-adrenoceptors stimulates renin and their blockade suppresses renin. 2 Although experimental renin regulation appears to be a beta 2-receptor function, clinical studies suggest that in man it is a beta 1 effect. 3 beta-Adrenoceptor-blocking agents are effective antihypertensive agents, but have variable effects on renin secretion; this variability may be attributable to different degrees of instrinsic partial beta-agonistic activity and/or different receptor or organ selectivity of various compounds. 4 Antihypertensive effectiveness seems unrelated in magnitude or timing to the baseline levels or the changes of plasma renin activity for the majority of beta-adrenoceptor-blocking drugs.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 37876      PMCID: PMC1429320     

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  36 in total

1.  Evidence for a renal alpha-adrenergic receptor inhibiting renin release.

Authors:  W A Pettinger; T K Keeton; W B Campbell; D C Harper
Journal:  Circ Res       Date:  1976-05       Impact factor: 17.367

2.  Effect of alprenolol on blood pressure and plasma renin activity in hypertensive patients.

Authors:  J Castenfors; H Johnsson; L Orö
Journal:  Acta Med Scand       Date:  1973-03

3.  The inhibition of renin secretion by alpha-adrenergic stimulation in the isolated rat kidney.

Authors:  R Vandongen; W S Peart
Journal:  Clin Sci Mol Med       Date:  1974-11

4.  Adrenergic receptor mediation of renin secretion.

Authors:  N Winer; D S Chokshi; M S Yoon; A D Freedman
Journal:  J Clin Endocrinol Metab       Date:  1969-09       Impact factor: 5.958

5.  The effect of chronic adrenergic receptor blockade on plasma renin activity in man.

Authors:  A M Michelakis; R G McAllister
Journal:  J Clin Endocrinol Metab       Date:  1972-02       Impact factor: 5.958

6.  Effect of practolol on blood pressure and renin release in man.

Authors:  M D Esler
Journal:  Clin Pharmacol Ther       Date:  1974-05       Impact factor: 6.875

7.  Effect of adrenoceptor-blocking agents on the renin response to isoproterenol in dogs.

Authors:  T A Assaykeen; H Tanigawa; D J Allison
Journal:  Eur J Pharmacol       Date:  1974-05       Impact factor: 4.432

8.  Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.

Authors:  F R Bühler; J H Laragh; L Baer; E D Vaughan; H R Brunner
Journal:  N Engl J Med       Date:  1972-12-14       Impact factor: 91.245

9.  Cardiovascular responses to carotid and vertebral artery infusions of propranolol.

Authors:  S Stern; M Hoffman; K Braun
Journal:  Cardiovasc Res       Date:  1971-10       Impact factor: 10.787

10.  The influence of potassium administration and of potassium deprivation on plasma renin in normal and hypertensive subjects.

Authors:  H R Brunner; L Baer; J E Sealey; J G Ledingham; J H Laragh
Journal:  J Clin Invest       Date:  1970-11       Impact factor: 14.808

View more
  3 in total

1.  An investigation into the type of beta-adrenoceptor mediating sympathetically activated renin release in the cat.

Authors:  E J Johns
Journal:  Br J Pharmacol       Date:  1981-07       Impact factor: 8.739

2.  Penbutolol: a preliminary review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-07       Impact factor: 9.546

Review 3.  Nadolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.

Authors:  R C Heel; R N Brogden; G E Pakes; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-07       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.